EUVIMEDEUVIMED entdecken
Crossref

Irritable bowel syndrome: low dose antidepressant improves symptoms

Helen Saul, Samantha Cassidy, Laura Swaithes, Alexander C Ford

BMJ · 2024

DOI: 10.1136/bmj.q871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMJ, 2024. Verfasst von Helen Saul und 3 weiteren Autor:innen. Beteiligte Einrichtung: NIHR Evidence, Twickenham, UK. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Amitriptyline. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The study Ford AC, Wright-Hughes A, Alderson SL, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2023;402:1773-85. To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/irritable-bowel-syndrome-low-dose-antidepressant-improves-symptoms/

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeAmitriptylineHumansDouble-Blind MethodAntidepressive AgentsRandomized Controlled Trials as TopicAntidepressive Agents, TricyclicTreatment OutcomeClinical Trials, Phase III as Topic

Substanzen

AmitriptylineAntidepressive AgentsAntidepressive Agents, Tricyclic

Autor:innen und Institutionen

  • NIHR Evidence, Twickenham, UK.
  • University of Leeds.

Zitieren

APA

Saul, H., Cassidy, S., Swaithes, L., & Ford, A. C. (2024). Irritable bowel syndrome: low dose antidepressant improves symptoms. BMJ. https://doi.org/10.1136/bmj.q871

Vancouver

Saul H, Cassidy S, Swaithes L, Ford AC. Irritable bowel syndrome: low dose antidepressant improves symptoms. BMJ. 2024. doi:10.1136/bmj.q871

BibTeX
@article{Saul2024,
  author = {Saul, Helen and Cassidy, Samantha and Swaithes, Laura and Ford, Alexander C},
  title = {Irritable bowel syndrome: low dose antidepressant improves symptoms},
  journal = {BMJ},
  year = {2024},
  doi = {10.1136/bmj.q871}
}
Kostenlos starten →